Sentences with phrase «pharmaceutical patents due»

Under the latter, Canada will, first, provide up to two years of supplementary protection to pharmaceutical patents due to delays in excess of five years between patent filing and market approval.

Not exact matches

Generic pharmaceutical company Teva brought the suit against Pfizer hoping to produce a generic version of Viagra before Pfizer's patent was due to expire in 2014.

Meanwhile, the patent term restoration provisions are likely to increase health care costs in Canada by delaying the availability of generic pharmaceuticals due to the extension in the term of protection for patented pharmaceuticals.

One of the few negatives on an otherwise fairly positive day of trading was the 5 % decline of Reckitt Benckiser, producers of a drug used to help get drug users off of Heroin called Suboxone, which acts as a replacement for the Class A. Reckitt's patent for Suboxone is due to expire in the relatively near future, so they have been trying to push doctors and other pharmaceutical vendors towards their film version of the drug, which is still under patent and will be for quite some time.

The fragmented but highly entrepreneurial Indian pharmaceutical industry has grown independently due to friendly process - patenting regulations and low - cost manufacturing structure.

For that reason, many pharmaceutical companies have tried on multiple occasions to patent turmeric but have been denied every time due to turmeric being a natural ingredient (fortunately for us!).

Coconut oil has the potential to aid in the protection and treatment of a number of health problems due to its documented antimicrobial, antioxidant, anti-inflammatory, antiulcerogenic, antimutagenic, analgesic, and antipyretic activities.33 - 34 Scientists and pharmaceutical companies have recognized the importance of MCTs and have filed numerous patents for their therapeutic use in the treatment of Alzheimer's disease, cancer, dental caries, periodontal disease, skin diseases, and various bacterial, viral, and fungal infections.

In addition to prosecuting patent applications on behalf of public and private institutions, biotechnology companies, and pharmaceutical companies, Dr. Rearick performs IP due diligence in a variety of in - licensing and investment contexts, with specific expertise in pharmaceuticals.

Dr. Gabor Brasnjo focuses on patent prosecution, strategic patent counseling, and intellectual property due diligence matters broadly in the life sciences sector, with an emphasis in the biotechnology and pharmaceutical industries.